Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Exploring Ferroptosis: A Key Mechanism in Respiratory System Diseases and its Therapeutic Potential.

Created on 16 Aug 2026

Authors

Zhongyu Han, Xiuli Xie, Haoran Chen, Ling Ding, Ruimin Yuan, Mingyu Huang, Lan Yuan, Yanmei Wang

Published in

Applied biochemistry and biotechnology. Aug 15, 2026. Epub Aug 15, 2026.

Abstract

Respiratory system diseases are currently the main cause of high incidence and mortality rates worldwide. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally. Currently, treatment outcomes are unsatisfactory. This is partly due to the incomplete elucidation of programmed cell death pathways. Ferroptosis is a lipid peroxidation-driven iron-dependent form of cell death. It has become a key mechanism in the study of respiratory system pathophysiology. We systematically explored the molecular basis of ferroptosis which includes core aspects such as iron metabolism disorders, lipid peroxidation and antioxidant defence. We also elaborate on the role of ferroptosis in COPD, pulmonary fibrosis, acute lung injury, lung cancer, asthma and pulmonary infections. We focus on summarizing emerging therapeutic targets and potential biomarkers via integrating new insights at the mechanism level and clinical significance. A deeper understanding of the above content will help promote the development of precise intervention strategies for respiratory system diseases.

PMID:
42603233
Bibliographic data and abstract were imported from PubMed on 16 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement